CEO Blog

PBS Price Cuts Undermine Long Term Innovation

April 2016: Earlier this week, pharmaceutical companies across the country copped a hefty financial blow, as the Federal Government’s PBS cost saving agenda took flight...

The PBS ‘Price’ Should Never Influence Cancer Treatment

August 2016: In Australia, the cost of treating some cancers is becoming more expensive

Guest Blog: Rare Cancers Australia chief Richard Vines discusses cancer drug access

September 2017: By Richard Vines, Chief Executive Officer and Co-Founder Rare Cancers Australia.

When Customers Come First, Not Dangling Carrots

February 2017: ST Chief Executive explains the rationale behind new company business model.